Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence
Clinical trial NCT01824823 · TERMINATED
Trial details
- NCT number
- NCT01824823
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-30
- Primary completion
- 2015-12-13
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.